Skye Bioscience Inc (SKYE)

[TheMonolith]

This approval signals the opening of an entirely new class of drugs, said Bill Dunn, the FDA's director of the division of Neurology Products. CBD is "one of more than 100 molecules derived from the cannabis plant and each molecule has its own pharmacology," he said.

Should help with this hope for non-dilutive financing.

They also believe they can package a pre-clinical deal, for one of their CBD analogs.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139932301